Concepedia

Emmanuel Guardiola

EG

32

Publications

1.4K

Citations

22

H-Index

2000

Active since

Affiliations

Centre Hospitalier Universitaire de Besançon(Current)

Centre Antoine Lacassagne

Inserm

Hôpital Privé Jean Mermo

Centre Hospitalier de la Dracénie

Emmanuel Guardiola is an author at Centre Hospitalier Universitaire de Besançon specializing in medicine, oncology, and cancer therapeutics.

Top concepts

Publications per year

2000–2021

32

Publications

32

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial

Jacobus Pfisterer, Catherine Shannon, Klaus Baumann et al. · The Lancet Oncology · 2020 · 157 citations

, , +8

Carboplatin-based doublet plus bevacizumab beyond progression versus carboplatin-based doublet alone in patients with platinum-sensitive ovarian cancer: a randomised, phase 3 trial

Sandro Pignata, Domenica Lorusso, Florence Joly et al. · The Lancet Oncology · 2021 · 144 citations

, , +7

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

Xavier Pivot, Gilles Romieu, Marc Debled et al. · The Lancet · 2019 · 125 citations

, , +6

Results of a randomised phase II study comparing docetaxel with methotrexate in patients with recurrent head and neck cancer

Emmanuel Guardiola, Frédéric Peyrade, L. Chaigneau et al. · European Journal of Cancer · 2004 · 117 citations

, , +9

Trastuzumab versus observation for HER2 nonamplified early breast cancer with circulating tumor cells (EORTC 90091-10093, BIG 1-12, Treat CTC): a randomized phase II trial

Michail Ignatiadis, Saskia Litière, Françoise Rothé et al. · Annals of Oncology · 2018 · 69 citations · Full text

Rows per page

1–5 of 32